Berlin - Delayed Quote EUR
Telix Pharmaceuticals Ltd (T3X.BE)
15.30
+0.12
+(0.82%)
At close: April 30 at 6:34:03 PM GMT+2
Loading Chart for T3X.BE
- Previous Close
15.17 - Open
15.26 - Bid 14.98 x --
- Ask 15.62 x --
- Day's Range
15.26 - 15.30 - 52 Week Range
8.93 - 22.49 - Volume
0 - Avg. Volume
26 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 20, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T3X.BE
View MorePerformance Overview: T3X.BE
Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
T3X.BE
3.14%
S&P/ASX 200 [XJO] (^AXJO)
0.17%
1-Year Return
T3X.BE
68.08%
S&P/ASX 200 [XJO] (^AXJO)
7.61%
3-Year Return
T3X.BE
395.46%
S&P/ASX 200 [XJO] (^AXJO)
9.56%
5-Year Return
T3X.BE
573.05%
S&P/ASX 200 [XJO] (^AXJO)
55.28%
Compare To: T3X.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: T3X.BE
View MoreValuation Measures
As of 4/30/2025
Market Cap
5.09B
Enterprise Value
5.02B
Trailing P/E
188.67
Forward P/E
62.50
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.02
Price/Book (mrq)
16.07
Enterprise Value/Revenue
11.43
Enterprise Value/EBITDA
96.73
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--